摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(4R,5R)-1,3-dibenzyl-5-(mercaptomethyl)imidazolidin-2-one-4-carboxylic acid | 112878-95-2

中文名称
——
中文别名
——
英文名称
(4R,5R)-1,3-dibenzyl-5-(mercaptomethyl)imidazolidin-2-one-4-carboxylic acid
英文别名
(4R,5R)-1,3-dibenzyl-5-mercaptomethyl-2-oxothiazolidine-4-carboxylic acid;(4R,5R)-1,3-dibenzyl-2-oxo-5-(mercaptomethyl)-imidazolidin-4-carboxylic acid;(4R,5R)-1,3-dibenzyl-2-oxo-5-(mercaptomethyl)imidazolidin-4-carboxylic acid;(4R,5R)-1,3-dibenzyl-2-oxo-5-mercaptomethylimidazolidine-4-carboxylic acid;(4R,5R)-1,3-dibenzyl-2-oxo-5-(sulfanylmethyl)imidazolidine-4-carboxylic acid
(4R,5R)-1,3-dibenzyl-5-(mercaptomethyl)imidazolidin-2-one-4-carboxylic acid化学式
CAS
112878-95-2
化学式
C19H20N2O3S
mdl
——
分子量
356.445
InChiKey
HJZIBQKDKBSYQR-DLBZAZTESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    159-160 °C
  • 沸点:
    605.8±55.0 °C(Predicted)
  • 密度:
    1.313±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    25
  • 可旋转键数:
    6
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.26
  • 拓扑面积:
    61.8
  • 氢给体数:
    2
  • 氢受体数:
    4

SDS

SDS:f08cd9417c6893a9a3d1cc2940af1065
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • A Practical Synthesis of (+)-Biotin fromL-Cysteine
    作者:Masahiko Seki、Masanori Hatsuda、Yoshikazu Mori、Shin-ichi Yoshida、Shin-ichi Yamada、Toshiaki Shimizu
    DOI:10.1002/chem.200400733
    日期:2004.12.3
    which is readily derived from L-cysteine through cyclization and elaboration of the carboxy group, was subjected to the Strecker reaction, which, via sodium bisulfite adduct 16, afforded alpha-amino nitrile 5 with high diastereoselectivity (syn/anti=11:1) and in high yield. Amide 6, derived from 5, was converted to thiolactone 8, a key intermediate in the synthesis of (+)-biotin (1), by a novel S,N-carbonyl
    易于通过环化和羧基化衍生自L-半胱氨酸的α-氨基醛4经受Strecker反应,该反应通过亚硫酸氢钠加合物16得到具有高非对映选择性的α-氨基腈5(syn /反= 11:1),且收率很高。通过新的S,N-羰基迁移和环化反应,将5衍生的酰胺6转化为硫代内酯8,这是合成(+)-生物素(1)的关键中间体。在非均相Pd / C催化剂的存在下,8与具有酯基的锌试剂21的福山偶联反应使4-羧基丁基链的有效安装提供了9。化合物9进行了氢化,保护基团去除后可分10步提供1种,L-半胱氨酸的总收率为34%。
  • An efficient and practical procedure for Strecker reaction: a highly diastereoselective synthesis of a key intermediate for (+)-biotin
    作者:Masahiko Seki、Masanori Hatsuda、Shin-ichi Yoshida
    DOI:10.1016/j.tetlet.2004.07.034
    日期:2004.8
    aqueous solution of 6 was treated with benzylamine followed by easy-handling NaCN to effect the Strecker reaction to afford α-amino nitrile 3 with high diastereoselectivity and in high yield (syn/anti = 11:1, 95% assay yield). Both the compounds syn-3 and anti-3 were converted to a key intermediate 4 for (+)-biotin through S,N-carbonyl migration in high yields.
    用亚硫酸氢钠水溶液处理相应的β-氨基醇5并通过Moffatt氧化制得的α-氨基醛2,可将其干净地转化为水溶性亚硫酸氢盐加合物6 [> 99%转化率,89%收率(两步) )]。用苄胺处理6的水溶液,然后用易处理的NaCN进行Strecker反应,以高非对映选择性和高收率(合成/抗 = 11:1,测定收率95%)提供α-氨基腈3。化合物syn - 3和anti - 3都被转化为关键中间体。4为(+) -生物素通过小号,Ñ以高收率羰迁移。
  • Intermediate for biotin and process for producing the same
    申请人:Seki Masahiko
    公开号:US20050038260A1
    公开(公告)日:2005-02-17
    The present invention is to provide a process for preparing a synthetic intermediate of biotin which is industrially advantageous, and discloses a process for preparing a compound represented by the formula (I): wherein R 1 and R 2 may be the same or different from each other, and each represents hydrogen atom, a benzyl group which may have a substituent(s) on the benzene ring, a benzhydryl group which may have a substituent(s) on the benzen ring, or a trityl group which may have a substituent(s) on the benzene ring, R 3 represents cyano group, carboxyl group, an alkoxycarbonyl group, an alkylthiocarbonyl group, or a carbamoyl group which may have a substituent, or a salt thereof which comprises subjecting a compound represented by the formula (II-a): wherein the symbols have the same meanings as defined above, or a salt thereof to ring transformation.
    本发明提供了一种制备生物素合成中间体的工业优势过程,并披露了一种制备由式(I)表示的化合物的过程:其中R1和R2可以相同也可以不同,分别代表氢原子、苯甲基,苯环上可能带有取代基的苯甲基,苯环上可能带有取代基的苯基甲基,或苯环上可能带有取代基的三苯甲基;R3代表氰基、羧基、烷氧基羰基、烷基硫酰基、或可能带有取代基的氨基甲酰基,或其盐;该过程包括将式(II-a)表示的化合物:其中符号具有上述定义的相同含义,或其盐进行环转化。
  • Biotin intermediate and process for preparing the same
    申请人:Seki Masahiko
    公开号:US20080119655A1
    公开(公告)日:2008-05-22
    The present invention is to provide a process for preparing a synthetic intermediate of biotin which is industrially advantageous, and discloses a process for preparing a compound represented by the formula (I): 1 wherein R 1 and R 2 may be the same or different from each other, and each represents hydrogen atom, a benzyl group which may have a substituent(s) on the benzene ring, a benzhydryl group which may have a substituent(s) on the benzen ring, or a trityl group which may have a substituent(s) on the benzene ring, R 3 represents cyano group, carboxyl group, an alkoxycarbonyl group, an alkylthiocarbonyl group, or a carbamoyl group which may have a substituent, or a salt thereof which comprises subjecting a compound represented by the formula (II-a): 2 wherein the symbols have the same meanings as defined above, or a salt thereof to ring transformation.
    本发明提供了一种制备生物素合成中间体的工业优势过程,并揭示了一种制备由式(I)表示的化合物的过程:其中R1和R2可以相同也可以不同,分别表示氢原子,苯基(苯环上可能有取代基),苯基甲基(苯环上可能有取代基),或三苯甲基(苯环上可能有取代基);R3表示氰基,羧基,烷氧基羰基,烷基硫氧基羰基或氨基甲酰基(可能带有取代基),或其盐,该过程包括将式(II-a)表示的化合物:其中符号具有上述定义的相同含义,或其盐进行环转化。
  • Novel practical stereoselective synthesis of a bicyclic hydantoino-thiolactone as the key intermediate for production of (+)-biotin
    作者:Lei Shu、Zhi-Wei Yang、Ren-Xu Cao、Xiao-Xia Qiu、Feng Ni、Xiao-Xin Shi
    DOI:10.1039/d3ra04721k
    日期:——
    Bicyclic hydantoinothiolactone (1), as the key intermediate for production of (+)-biotin, has been efficiently and high-stereoselectively synthesized from the cheap starting material l-cystine via nine steps in 44% overall yield. In this new practical synthesis, there are two characteristic steps worthy of note. One step is TMSOTf-catalyzed efficient cyanation of (3S,7aR)-6-benzyl-5-oxo-3-phenyltetrahydro-1H
    双环乙内酰硫代内酯 (1) 作为生产 (+)-生物素的关键中间体,以廉价的起始原料 L-胱氨酸为原料,经过九步高效、高立体选择性合成,总产率为 44%。在这个新的实用合成中,有两个特征步骤值得注意。第一步是TMSOTf催化(3S,7aR)-6-苄基-5-氧代-3-苯基四氢-1H,3H-咪唑并[1,5-c]噻唑-7-乙酸酯的高效氰化,另一步是DBU 催化双环乙内酰硫内酯的反式异构体快速异构化为顺式异构体。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物